These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2431344)

  • 21. Chronic treatment with antidepressants: protentiation of clonidine-induced aggression in mice via noradrenergic mechanism.
    Maj J; Mogilnicka E; Klimek V; Kordecka-Magiera A
    J Neural Transm; 1981; 52(3):189-97. PubMed ID: 6458665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of agreement between the salivary flow and finger-sweat print methods for the determination of the anticholinergic effects of antidepressant drugs.
    Carlini EL; Del-Porto JA; Zwicker AP
    Braz J Med Biol Res; 1985; 18(2):163-9. PubMed ID: 3913478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The serotonin reuptake inhibitor paroxetin is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome.
    Eriksson E; Hedberg MA; Andersch B; Sundblad C
    Neuropsychopharmacology; 1995 Apr; 12(2):167-76. PubMed ID: 7779245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mirtazapine : A Review of its Pharmacology and Therapeutic Potential in the Management of Major Depression.
    Davis R; Wilde MI
    CNS Drugs; 1996 May; 5(5):389-402. PubMed ID: 26071050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison between a serotonin and a noradrenaline reuptake blocker in the treatment of depressed outpatients. Biochemical aspects.
    Nyström C; Ross SB; Hällström T; Kelder D
    Acta Psychiatr Scand; 1986 Feb; 73(2):133-8. PubMed ID: 2939691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Viloxazine as a betamimetic antidepressant drug.
    Bourin M; Ortega A; Larousse C
    Neuropsychobiology; 1987; 17(1-2):35-40. PubMed ID: 2819765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular, sedative and anticholinergic effects of amitriptyline and zimelidine in young and elderly volunteers.
    Swift CG; Haythorne JM; Clarke P; Stevenson IH
    Acta Psychiatr Scand Suppl; 1981; 290():425-32. PubMed ID: 6452804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison between a serotonin and a noradrenaline reuptake blocker in the treatment of depressed outpatients. A cross-over study.
    Nyström C; Hällström T
    Acta Psychiatr Scand; 1987 Apr; 75(4):377-82. PubMed ID: 3035878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Norzimelidine, a metabolite of a highly selective 5-hydroxytryptamine uptake inhibitor, can inhibit the uptake of noradrenaline in-vivo.
    Pawłowski L; Mazela H
    J Pharm Pharmacol; 1984 Dec; 36(12):855-8. PubMed ID: 6151986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A study to assess the anticholinergic activity of rolipram in healthy elderly volunteers.
    Ross CE; Toon S; Rowland M; Murray GH; Meya U
    Pharmacopsychiatry; 1988 Sep; 21(5):222-5. PubMed ID: 3227053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relative speed of onset of the antidepressant effect of maprotiline.
    Silverstone T
    Clin Ther; 1981; 3(5):374-81. PubMed ID: 7471133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maprotiline: an antidepressant with an unusual pharmacological profile.
    Barbaccia ML; Ravizza L; Costa E
    J Pharmacol Exp Ther; 1986 Feb; 236(2):307-12. PubMed ID: 3003338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Different effects of tricyclic (clomipramine and amitriptyline) and tetracyclic (maprotiline) antidepressors on the release of thyroid stimulating hormone, prolactin and growth hormone to thyrostimulating releasing hormone in patients with psychoaffective disorders (author's transl)].
    Schlienger JL; Kapfer MT; Singer L; Stephan F
    Acta Psychiatr Belg; 1980; 80(5):584-99. PubMed ID: 6786002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific norepinephrine and serotonin uptake inhibitors in man: a crossover study with pharmacokinetic, biochemical, neuroendocrine and behavioral parameters.
    Potter WZ; Calil HM; Extein I; Gold PW; Wehr TA; Goodwin FK
    Acta Psychiatr Scand Suppl; 1981; 290():152-65. PubMed ID: 6452790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of zimelidine and amitriptyline on the brain concentration of some indolic and phenolic monoamines in the mouse.
    Juorio AV; Boulton AA
    Eur J Pharmacol; 1984 Jan; 97(3-4):191-6. PubMed ID: 6200338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Profile of antidepressant action of zimelidine and norzimelidine compared with amitriptyline.
    Montgomery SA; Montgomery DB; McAuley R; Rani SJ; Roy D
    Adv Biochem Psychopharmacol; 1982; 32():35-42. PubMed ID: 6211942
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effects of 3 doses of maprotiline (25, 50 and 75 mg) on alertness and memory in healthy volunteers].
    Warot D; Danjou P; Lacomblez L; Diquet B; Puech AJ
    Therapie; 1989; 44(4):257-61. PubMed ID: 2595643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Zimelidine-induced variations in alcohol intake by nondepressed heavy drinkers.
    Naranjo CA; Sellers EM; Roach CA; Woodley DV; Sanchez-Craig M; Sykora K
    Clin Pharmacol Ther; 1984 Mar; 35(3):374-81. PubMed ID: 6230195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of physical exercise on salivary secretion of MUC5B, amylase and lysozyme.
    Ligtenberg AJ; Brand HS; van den Keijbus PA; Veerman EC
    Arch Oral Biol; 2015 Nov; 60(11):1639-44. PubMed ID: 26351746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical trials with new bicyclic and tetracyclic compounds: zimelidine and maprotiline [proceedings].
    Claghorn JL; Mathew RJ
    Psychopharmacol Bull; 1981 Jan; 17(1):23-6. PubMed ID: 6453355
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.